ReProMSig: an integrative platform for development and application of reproducible multivariable models for cancer prognosis supporting guideline-based transparent reporting

ReProMSig (Reproducible Prognosis Molecular Signature) has been online at Briefings in Bioinformatics. Congratulations to Tingting Zhao and Lihua Cao!

Avatar
Jianmin Wu
Director,
Center for Cancer Bioinformatics

Member,
ICGC-ARGO Scientific Planning Committee
Next
Previous